Related Experiment Video
Updated: Aug 4, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Collecting and assessing human lactate dehydrogenase-A conformations for structure-based virtual screening
Rosa Buonfiglio1, Mariarosaria Ferraro, Federico Falchi
1Department of Pharmacy and Biotechnology, Alma Mater Studiorum-Università di Bologna , via Belmeloro 6, 40126 Bologna, Italy.
Human lactate dehydrogenase-A (LDHA) is a potential anticancer target. This study reveals flexible active site conformations for improved drug design, validated by virtual screening.
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology and Drug Discovery
- Computational Chemistry
Background:
- Human lactate dehydrogenase-A (LDHA) is a key enzyme in cancer metabolism and a promising anticancer target.
- Previous structure-based drug design efforts for LDHA inhibitors have overlooked the enzyme's active site flexibility.
- Understanding LDHA's dynamic nature is crucial for developing effective and specific inhibitors.
Purpose of the Study:
- To identify reliable human lactate dehydrogenase-A (LDHA) conformations by accounting for active site flexibility.
- To provide a foundation for structure-based ligand design targeting LDHA.
- To validate the identified conformations using virtual screening methods.
Main Methods:
- Utilized replica exchange molecular dynamics (REMD) simulations to explore LDHA conformational space.
- Applied network and cluster analyses to identify stable and relevant LDHA conformations.
- Performed retrospective virtual screening to challenge and validate the selected conformations.
Main Results:
- Successfully identified reliable LDHA conformations that capture active site flexibility.
- The selected conformations proved effective in retrospective virtual screening, validating their utility.
- This approach offers a more accurate representation of the enzyme for inhibitor design.
Conclusions:
- Accounting for active site flexibility is essential for successful structure-based LDHA inhibitor design.
- The identified LDHA conformations provide a robust basis for developing novel anticancer therapeutics.
- This study enhances the potential of targeting LDHA in cancer treatment.
More Related Videos
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Related Concept Videos
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...